Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Pharma Production Rose 18% in 2013

publication date: Feb 24, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China's pharmaceutical output in 2013 rose 18% to $355.4 billion, while profits were up 17.6% at $36 billion, according to the figures published by the National Development and Reform Commission. TCM preparations did especially well, said the agency. On the other hand, the agency blamed weak economies in the US and Europe for keeping China’s drug industry from doing even better. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...